Odyssean LLC’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.4M Buy
+5,805
New +$4.39M 0.51% 22
2026
Q2
– Sell
-1,957
Closed -$1.51M – 555
2026
Q1
$1.51M Buy
1,957
+989
+102% +$757K 0.55% 15
2025
Q4
$747K Buy
+968
New +$657K 0.54% 44

Other funds holding REGN

Odyssean LLC's REGN Position: Q3 2026 in Review

Odyssean LLC opened a new position in Regeneron Pharmaceuticals (REGN) in Q3 2026: 5,805 shares worth $4.4M. The stake represents 0.51% of the portfolio and ranks #22 among its holdings. This is a return to the name: Odyssean LLC previously reported a position in REGN as recently as Q1 2026.

Odyssean LLC first reported a position in REGN in Q4 2025 and has held it in 3 quarters since. 1,433 funds tracked by Wall St. Rank hold REGN as of Q3 2026.

  • Odyssean LLC held 5,805 shares of Regeneron Pharmaceuticals worth $4.4M as of Q3 2026.
  • Regeneron Pharmaceuticals was a new Odyssean LLC position in Q3 2026.
  • Regeneron Pharmaceuticals made up 0.51% of Odyssean LLC's portfolio in Q3 2026, its #22 holding.
  • Odyssean LLC first reported a position in Regeneron Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 1,433 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.

Based on Odyssean LLC's 13F filing for Q3 2026, filed 16 Nov 2026.